Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Cole C. Khamnei"'
Autor:
Adam J. Widman, Minita Shah, Nadia Øgaard, Cole C. Khamnei, Amanda Frydendahl, Aditya Deshpande, Anushri Arora, Mingxuan Zhang, Daniel Halmos, Jake Bass, Theophile Langanay, Srinivas Rajagopalan, Zoe Steinsnyder, Will Liao, Mads Heilskov Rasmussen, Sarah Østrup Jensen, Jesper Nors, Christina Therkildsen, Jesus Sotelo, Ryan Brand, Ronak H. Shah, Alexandre Pellan Cheng, Colleen Maher, Lavinia Spain, Kate Krause, Dennie T. Frederick, Murtaza S. Malbari, Melissa Marton, Dina Manaa, Lara Winterkorn, Margaret K. Callahan, Genevieve Boland, Jedd D. Wolchok, Ashish Saxena, Samra Turajlic, Marcin Imielinski, Michael F. Berger, Nasser K. Altorki, Michael A. Postow, Nicolas Robine, Claus Lindbjerg Andersen, Dan A. Landau
In solid tumor oncology, circulating tumor DNA (ctDNA) is poised to transform care through accurate assessment of minimal residual disease (MRD) and therapeutic response monitoring. To overcome the sparsity of ctDNA fragments in low tumor fraction (T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ca96a3c3d9882a10f4e1302b660b4560
https://doi.org/10.1101/2022.01.17.476508
https://doi.org/10.1101/2022.01.17.476508
Autor:
Dan A. Landau, Cole C. Khamnei, Nicolas Robine, Margaret K. Callahan, Adam J Widman, Minita Shah, Jake Bass, Jedd D. Wolchok, Will Liao
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Background Clearance of circulating tumor DNA (ctDNA) following checkpoint blockade (CB) can precede radiographic response,1 2 though current state of the art ctDNA detection via targeted panels faces limited sensitivity in low burden disease (figure
Autor:
Steven T. K. Hill, Rafael C. Schulman, Margaret K. Callahan, Patrick O. Bolan, Gavin Ha, Nicolas Robine, Sunil Deochand, Chelston Ang, Brian Houck-Loomis, Adam J. Widman, Asaf Zviran, Catherine F. Spinelli, Christian Stolte, Viktor A. Adalsteinsson, Alexi M. Runnels, Giorgio Inghirami, Sarah C. Reed, Federico Gaiti, Benchun Miao, Jedd D. Wolchok, Cole C. Khamnei, Nasser K. Altorki, Samantha Fennessey, Murtaza Malbari, Genevieve M. Boland, Will Liao, Dillon Maloney, Jennifer Ishii, Tatyana Sharova, Kevin Y. Huang, Kristofer Patel, Tommy Kim, Nathaniel D. Omans, Denisse Rotem, Dan A. Landau, Andrew Lipsky, Justin Rhoades, Selena Kazancioglu, Greg Gydush, Minita Shah, Phillip Wong, Dennie T. Frederick
Publikováno v:
Nat Med
In many areas of oncology, we lack sensitive tools to track low-burden disease. Although cell-free DNA (cfDNA) shows promise in detecting cancer mutations, we found that the combination of low tumor fraction (TF) and limited number of DNA fragments r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a39e84c85ee6c6a61dd9d8a91de2d20
https://europepmc.org/articles/PMC8108131/
https://europepmc.org/articles/PMC8108131/
Autor:
Gomez K, Schiavoni G, Nam Y, Reynier JB, Khamnei C, Aitken M, Palmieri G, Cossu A, Levine A, van Noesel C, Falini B, Pasqualucci L, Tiacci E, Rabadan R
Publikováno v:
MedRxiv : the preprint server for health sciences [medRxiv] 2023 Feb 16. Date of Electronic Publication: 2023 Feb 16.